Neovii Competitors and Similar CompaniesClear all
Neovii's competitors and similar companies include Alpha Tau Medical, Minerva Biotechnologies and NKGen Biotech.
 Neovii Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
|  Alpha Tau Medical Alpha Tau Medical focuses on research, development, and commercialization of diffusing alpha-emitters radiation therapy (DaRT) for the treatment of solid cancer tumors. |  Minerva Biotechnologies Minerva Biotechnologies is a company focused on cancer and stem cell therapeutics. |  NKGen Biotech NKGen Biotech (formerly known as NKMax America) is a biotechnology company that develops cell therapies for neurodegenerative and oncological diseases based on activated NK cells. | |
Founding Date | Founding Date 2003 | Founding Date 2016 | Founding Date 1999 | Founding Date 2017 |
Type | Type Private | Type Private | Type Private | Type Public |
Tags | ||||
Locations | Locations Rapperswil-Jona, CH HQ Gräfelfing, DE Lexington, US | Locations Tel Aviv-Yafo, IL HQ Boston, US | Locations Waltham, US HQ | Locations Santa Ana, US HQ |
Employees | Employees 1193% increase | Employees 1041% increase | Employees 19 | Employees 7316% increase |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 26m (about 6 years ago) | Latest funding round $ 29m (over 7 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 55m | Total funding raised $ 37.2m | Total funding raised $ 11m |
For sources of this data, please see the company profile
View Company Profiles
Alpha Tau Medical
HQ
Tel Aviv-Yafo, IL
Employees
104↑ 1% increase
Alpha Tau Medical focuses on research, development, and commercialization of diffusing alpha-emitters radiation therapy (DaRT) for the treatment of solid cancer tumors.
View companyMinerva Biotechnologies
HQ
Waltham, US
Employees
19
Minerva Biotechnologies is a company focused on cancer and stem cell therapeutics.
View companyNKGen Biotech
HQ
Santa Ana, US
Employees
73↑ 16% increase
NKGen Biotech (formerly known as NKMax America) is a biotechnology company that develops cell therapies for neurodegenerative and oncological diseases based on activated NK cells.
View company